Fig. 5From: Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapyChallenges and overcoming strategies of CRISPR/Cas9. Immunogenicity, off-targeting, polymorphism, delivery technique, and ethical issues are main limitations, difficulties; and challenges of the CRISPR/Cas9 system in clinical trials and its recent discovery and usage in humansBack to article page